解释贫水作为癌症疗法:一个叙事评论
Anthony M Kyriakopoulos1, Stephanie Seneff2
1Laboratory of Molecular Biology and Immunology, Department of Pharmacy, University of Patras, Rio-Patras, Greece.
概括
癌细胞改变新陈代谢来控制水平,影响增殖或亡. 贫水 (DDW) 显示出作为抗癌治疗的希望,尽管需要对自的进一步研究.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 是一种重同位素,具有独特的生物物理和生物化学特性.
- 线粒体功能障碍,以过度反应性氧物种 (ROS) 和降低ATP生产为特征,与癌症和其他疾病有关.
- 癌细胞表现出改变的代谢策略,包括依赖糖解和乳酸生产,以管理细胞压力并促进增殖.
研究的目的:
- 研究在癌细胞代谢和行为中的作用.
- 探索贫水 (DDW) 作为抗癌治疗策略的潜力.
主要方法:
- 对对酶活性和线粒体功能的影响的分析.
- 对癌细胞代谢适应的观察,包括糖解,乳酸合成和V-ATPase活性.
- 对支持DDW在癌症治疗中的临床证据的审查.
主要成果:
- 乳破坏了线粒体的ATPase,增加了ROS,降低了ATP的产生.
- 癌细胞通过最小化线粒体ATP合成和增加糖解来适应,从而导致乳酸盐的产生.
- 癌细胞利用V-ATPases来调节细胞质水平,影响增殖或亡.
- 瘤发生涉及一种代谢转变,有利于更高的细胞水平.
结论:
- 癌细胞的新陈代谢对含量敏感,影响其生存和增殖.
- 贫水 (DDW) 显示出作为抗癌治疗的潜力.
- 对DDW对癌细胞自的作用进行进一步的研究是有必要的,以优化临床应用.
更多相关视频
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
2.8K
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.9K
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
